About Us

As a software and reagent technology company with a focus on bioinformatics, ChromaCode is pioneering advancements by integrating reliable biochemical techniques with computational mathematics to enhance performance in testing, at a very low cost.

ChromaCode’s team includes data scientists, molecular biologists, software engineers and employees experienced in commercialization of products and services. We strive to offer high-performing products partnered with best-in-class service to make our customer’s job successful.


Connecting patients to the right treatment through smarter and more affordable diagnostics.

mission and bullseye icon representing our bioinformatics mission and digital droplet PCR DPCR Mission

We merge novel data analytics and biochemistry strategies to:

Improve patient results by delivering advanced comprehensive diagnostics

Enhance physicians’ access to information by making clinically-actionable data readily available

Reduce healthcare costs by delivering high-quality, low-cost Dx tools


At ChromaCode, our values mean everything. Aligning with our values allows us to deliver the products and services our customers deserve.

check list icon, regarding bioinformatics


  • We make data-driven decisions
  • We are smart about the risks we take
  • We are proud to show our work and we embrace scrutiny
shield and check icon, bioinformatics


  • We rely on each other
  • We treat each other with respect
  • We are fair and honest with our colleagues and customers
Achieve bioinformatics icon, with a flag and two people holding it.


  • We create quality solutions that thrill customers
  • We are milestone- and goal-oriented
  • We work intelligently to deliver on-time, on-spec and on-budget
icon of people celebrating, development of digital droplet PCR and DPCR


  • We take joy in solving customers’ problems
  • We publicize individual and company achievements
  • We celebrate success

Who We Are

Our teams are diverse in both experience and culture. We enjoy learning from each other and sharing our stories. ChromaCodians work hard and play hard, especially when we have a reason to celebrate. From bi-weekly company meetings to holiday celebrations to friendly competitions, we know how to balance work and life.


2011 HDPCR TM idea percolated CalTech 2013 A. Rajagopal publishes on HDPCR TM 2014 Core HDPCR TM patent issues 2015 Series A funding used to start ChromaCode 2020 MDR and SARS-CoV-2 launch First prototype assay for multiplexed respiratory 2016 viruses using existing qPCR instruments Series B funding used to move 2017 into product development 2019 Series C funding Expansion of technology-added dPCR to qPCR capabilities, 2017 expanded coding schemes from binary to resilient TM technology on Digital PCR (dPCR), Demonstrated HDPCR Technology and first product launched-Tick-Borne Pathogen Panel 2018